CCE Stock Recent News Coca-Cola Enterprises (CCE) 42.72 11/09/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Coca-Cola Enterprises (CCE) 42.72 $CCE

Is Coca-Cola Enterprises Inc Spending This $1 Billion Wisely?
Ted Cooper, The Motley Fool - Motley Fool - Fri Oct 31, 9:00AM CDT
Last December, Coca-Cola Enterprises announced it would repurchase an additional $1 billion of its shares in the coming years -- its fourth such authorization in as many years. At the time, Coca-Cola Enterprises' stock was at an all-time high,...
CCE: 42.72 (-0.14)

Zacks Rank #5 Additions for Thursday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Thursday
AIRM: 42.95 (-3.69), CBR: 3.35 (+0.05), CCE: 42.72 (-0.14), AIR: 26.37 (-0.10), AEGN: 19.28 (+0.12)

Third Quarter Earnings - Research Reports on Carter's, Skechers, Dana, Coca-Cola and Autoliv
PR Newswire - Tue Oct 28, 8:15AM CDT
Today, Analysts Review released its research reports regarding Carter's, Inc. (NYSE: CRI), Skechers USA Inc. (NYSE: SKX), Dana Holding Corporation (NYSE: DAN), Coca-Cola Enterprises Inc. (NYSE: CCE) and Autoliv, Inc. (NYSE: ALV). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7493-100free.
ALV: 93.51 (-0.31), SKX: 57.60 (-0.11), DAN: 20.37 (-0.28), CRI: 79.16 (-0.41), CCE: 42.72 (-0.14)

Coca-Cola Enterprises Beats Earnings; Lowers Sales View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 11:10AM CDT
Coca-Cola Enterprises Inc. (CCE) announced dismal third-quarter 2014 earnings.
KO: 42.32 (+0.03), MNST: 108.39 (+7.91), GMCR: 152.90 (-0.16), CCE: 42.72 (-0.14)

Shares of CCE Down 7.6% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Thu Oct 23, 9:54AM CDT
SmarTrend identified a Downtrend for Coca-Cola Enterprises (NYSE:CCE) on September 5th, 2014 at $46.60. In approximately 2 months, Coca-Cola Enterprises has returned 7.64% as of today's recent price of $43.04.
CCE: 42.72 (-0.14)

Coca-Cola Enterprises tops 3Q earnings expectations
Automated Insights - Thu Oct 23, 7:01AM CDT
ATLANTA (AP) _ Coca-Cola Enterprises Inc. (CCE) on Thursday reported third-quarter net income of $238 million.
CCE: 42.72 (-0.14)

Coca-Cola Enterprises, Inc. Reports Third-Quarter 2014 Results and Full-Year Earnings Outlook
Business Wire - Thu Oct 23, 6:32AM CDT
--Net sales totaled $2.1 billion, down 11/2 percent on a reported basis, or down 31/2 percent on a currency-neutral basis; volume declined 4 percent.
CCE: 42.72 (-0.14)

Zacks Rank #5 Additions for Wednesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Oct 22, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Wednesday
AVD: 12.06 (+0.17), CVCY: 10.83 (-0.16), CCE: 42.72 (-0.14), AIR: 26.37 (-0.10), GTLS: 46.95 (+1.39)

Coca-Cola Enterprises, Inc. Declares Regular Quarterly Dividend
Business Wire - Mon Oct 20, 3:05PM CDT
The Coca-Cola Enterprises (NYSE: CCE)(Euronext Paris: CCE) Board of Directors declared a regular quarterly dividend of 25 cents per share. The dividend is payable December 4, 2014 to shareowners of record on November 21, 2014.
CCE: 42.72 (-0.14)

Can Coca-Cola Enterprises (CCE) Surprise Q3 Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 20, 1:20PM CDT
Coca-Cola Enterprises Inc. (CCE) is set to report the third-quarter fiscal 2014 results on Oct 23, before the market opens.
WWAV: 36.93 (-0.53), KO: 42.32 (+0.03), HSY: 96.43 (-0.39), CCE: 42.72 (-0.14)

Coca-Cola Enterprises Down 14.8% Since SmarTrend Downtrend Call (CCE)
Comtex SmarTrend(R) - Thu Oct 16, 9:34AM CDT
SmarTrend identified a Downtrend for Coca-Cola Enterprises (NYSE:CCE) on September 5th, 2014 at $46.60. In approximately 1 month, Coca-Cola Enterprises has returned 14.79% as of today's recent price of $39.71.
CCE: 42.72 (-0.14)

Zacks Industry Outlook Highlights: Unilever, Coca-Cola Enterprises, Kimberly-Clark, PepsiCo and Procter & Gamble
PR Newswire - Wed Oct 15, 8:30AM CDT
Today, Zacks Equity Research discusses the Consumer Staples (part 3), including Unilever plc (NYSE:UL-Free Report), Coca-Cola Enterprises, Inc. (NYSE:CCE-Free Report), Kimberly-Clark Corp. (NYSE:KMB-Free Report), PepsiCo Inc. (NYSE EP-Free Report) and Procter & Gamble Co. (NYSE G-Free Report).
KMB: 113.24 (+0.19), UL: 39.98 (+0.02), CCE: 42.72 (-0.14), PEP: 96.80 (-0.01)

Macroeconomic Factors Weigh on Consumer Staples Stocks - Zacks Analyst Interviews
Zacks Equity Research - Zacks Investment Research - Tue Oct 14, 3:39AM CDT
Macroeconomic Factors Weigh on Consumer Staples Stocks - Zacks Analyst Interviews
DPS: 69.95 (+0.01), KO: 42.32 (+0.03), MDLZ: 37.76 (-0.08), KMB: 113.24 (+0.19), TAP: 77.18 (+0.13), PG: 89.13 (+0.23), UL: 39.98 (+0.02), CCE: 42.72 (-0.14), DEO: 116.30 (-0.44), K: 63.66 (-0.87), PEP: 96.80 (-0.01)

Macroeconomic Factors Weigh on Consumer Staples Stocks - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Tue Oct 14, 3:39AM CDT
Macroeconomic Factors Weigh on Consumer Staples Stocks - Industry Outlook
DPS: 69.95 (+0.01), KO: 42.32 (+0.03), MDLZ: 37.76 (-0.08), KMB: 113.24 (+0.19), TAP: 77.18 (+0.13), PG: 89.13 (+0.23), UL: 39.98 (+0.02), CCE: 42.72 (-0.14), DEO: 116.30 (-0.44), K: 63.66 (-0.87), PEP: 96.80 (-0.01)

Are Cost-Control Measures Driving Consumer Staples? - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Mon Oct 13, 3:37AM CDT
Are Cost-Control Measures Driving Consumer Staples? - Industry Outlook
MDLZ: 37.76 (-0.08), MKC: 72.76 (-0.11), GMCR: 152.90 (-0.16), KMB: 113.24 (+0.19), SYY: 38.14 (+0.15), LO: 62.08 (+0.10), KRFT: 57.87 (-0.40), CCE: 42.72 (-0.14), SJM: 104.84 (-0.96), PEP: 96.80 (-0.01), K: 63.66 (-0.87), DPS: 69.95 (+0.01), SBUX: 77.79 (+0.34), DNKN: 47.04 (-0.01), RAI: 64.58 (+0.17), KO: 42.32 (+0.03), BUD: 108.34 (-0.16), UN: 38.53 (+0.02), TAP: 77.18 (+0.13), TSN: 41.11 (-0.42), UL: 39.98 (+0.02), MO: 49.87 (+0.31), WWAV: 36.93 (-0.53), PM: 88.12 (+0.62), UNFI: 71.89 (+1.29), BGS: 29.25 (-0.05), PG: 89.13 (+0.23), GIS: 51.36 (-1.91)

How Will Coca-Cola Enterprises (CCE) Stock Be Affected Today by This Analyst Action?
at The Street - Mon Oct 06, 7:32AM CDT
Nomura Group upgraded Coca-Cola Enterprises (CCE) to 'neutral' from 'reduce' with a price target of $134.
CCE: 42.72 (-0.14)

Upgrade Alert for Coca-Cola Enterprises (CCE)
Comtex SmarTrend(R) - Mon Oct 06, 6:57AM CDT
Coca-Cola Enterprises (NYSE:CCE) was upgraded from Reduce to Neutral at Nomura today. The stock closed yesterday at $44.08 on volume of 3.2 million shares, above average daily volume of 1.8 million. Coca-Cola Enterprises (NYSE:CCE) has potential upside of 14.6% based on a current price of $44.08 and analysts' consensus price target of $50.53. Coca-Cola Enterprises shares should first meet resistance at the 200-day moving average (MA) of $46.04 and find additional resistance at the 50-day MA of $46.25.
CCE: 42.72 (-0.14)

Coca-Cola Enterprises, Inc. to Webcast Third-Quarter 2014 Earnings Conference Call
Business Wire - Thu Sep 25, 8:00AM CDT
Coca-Cola Enterprises (NYSE: CCE) (Euronext Paris: CCE) will release third-quarter 2014 earnings before the market opens on Thursday, October 23.
CCE: 42.72 (-0.14)

Look for Shares of Coca-Cola Enterprises to Potentially Rebound after Yesterday's 2.30% Sell Off
Comtex SmarTrend(R) - Tue Sep 23, 5:21PM CDT
Coca-Cola Enterprises (NYSE:CCE) traded in a range yesterday that spanned from a low of $45.03 to a high of $45.92. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $45.67 on volume of 2.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CCE: 42.72 (-0.14)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Exciting New Development Partnership in Wasaga Beach Focuses on Growth

Updated Category News Views 262

New Development Partnership Announcement Sunray Group of Hotels is excited to announce a letter of intent for a new development project alongside the Town of Wasaga Beach. This venture, located at the intersection of First Street North and Beach Drive, is strategically positioned on four acres of valuable land across from Beach Area One. The proposed project consists of a...

Continue Reading
iGlobal Media USA Launches $500,000 Investment Round for Growth

Updated Category News Views 231

iGlobal Media USA Opens Investment Round for Expansion iGlobal Media USA, a leading name in digital broadcasting, is excited to announce a new opportunity for investors with a significant investment round aimed at raising $500,000. This funding will be pivotal for accelerating the national expansion of its advanced cloud-based radio platform, which promises to...

Continue Reading
STMicroelectronics Shares Update: Share Repurchase Program Details

Updated Category News Views 156

STMicroelectronics Shares Update on Repurchase Program STMicroelectronics N.V. (the "Company" or "STMicroelectronics"), a prominent name in the semiconductor industry, has actively engaged in a share repurchase program aimed at enhancing shareholder value. This program, initially revealed in a previous announcement, serves as a testament to the Company's commitment to...

Continue Reading
Chicago Mayor Brandon Johnson Set to Tackle Key Issues in D.C.

Updated Category News Views 103

Chicago Mayor Brandon Johnson to Speak at National Press Club Join us for an insightful luncheon featuring Chicago Mayor Brandon Johnson as he takes the stage at the National Press Club. This important event is set for the 28th of January, providing a platform for the Mayor to discuss pressing topics affecting residents. Event Overview The Headliners Luncheon will kick...

Continue Reading
BioCryst Pharmaceuticals Reveals HRU Improvements with ORLADEYO

Updated Category News Views 184

BioCryst Pharmaceuticals Introduces New HRU Findings BioCryst Pharmaceuticals, Inc. has recently shared compelling evidence regarding their product, ORLADEYO (berotralstat), that highlights its impact on reducing healthcare resource utilization for patients suffering from hereditary angioedema (HAE). This important finding underscores the therapy's role not only in...

Continue Reading